Novartis Ag (NVSEF) Cash & Equivalents (QoQ) (2019 - 2024)

Novartis Ag (NVSEF) Cash & Equivalents (QoQ) (2019 - 2024) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Novartis Ag - - -

Historic Data

Download Data
DateValue
Dec 31, 2024 2.54%
Sep 30, 2024 -97.01%
Jun 30, 2024 -99.60%
Mar 31, 2024 14,833.17%
Dec 31, 2023 1,966.82%
Sep 30, 2023 -94.05%
Dec 31, 2022 8,442.05%
Sep 30, 2022 -1.12%
Jun 30, 2022 27.14%
Mar 31, 2022 -99.44%
Dec 31, 2021 123,970.00%
Sep 30, 2021 66.67%
Jun 30, 2021 0.00%
Mar 31, 2021 -99.94%
Dec 31, 2020 12,607.89%
Sep 30, 2020 0.00%
Jun 30, 2020 0.00%
Mar 31, 2020 -99.32%
Jun 30, 2019 1,902.20%
Mar 31, 2019 -96.24%